XRAY vs. WST
Compare and contrast key facts about DENTSPLY SIRONA Inc. (XRAY) and West Pharmaceutical Services, Inc. (WST).
Performance
XRAY vs. WST - Performance Comparison
Loading graphics...
XRAY vs. WST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XRAY DENTSPLY SIRONA Inc. | 1.49% | -36.84% | -45.28% | 13.50% | -42.11% | 7.32% | -6.59% | 53.14% | -43.00% | 14.66% |
WST West Pharmaceutical Services, Inc. | -8.82% | -15.73% | -6.75% | 49.97% | -49.70% | 65.88% | 89.05% | 54.13% | -0.08% | 17.02% |
Fundamentals
XRAY:
$2.32B
WST:
$18.22B
XRAY:
-$2.99
WST:
$6.79
XRAY:
0.63
WST:
5.93
XRAY:
1.73
WST:
5.74
XRAY:
$3.68B
WST:
$3.07B
XRAY:
$1.84B
WST:
$1.10B
XRAY:
$7.00M
WST:
$723.60M
Returns By Period
In the year-to-date period, XRAY achieves a 1.49% return, which is significantly higher than WST's -8.82% return. Over the past 10 years, XRAY has underperformed WST with an annualized return of -14.13%, while WST has yielded a comparatively higher 13.95% annualized return.
XRAY
- 1D
- 3.57%
- 1M
- -20.98%
- YTD
- 1.49%
- 6M
- -7.27%
- 1Y
- -19.39%
- 3Y*
- -31.49%
- 5Y*
- -27.25%
- 10Y*
- -14.13%
WST
- 1D
- 2.24%
- 1M
- -1.45%
- YTD
- -8.82%
- 6M
- -4.29%
- 1Y
- 12.35%
- 3Y*
- -9.99%
- 5Y*
- -2.27%
- 10Y*
- 13.95%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XRAY vs. WST — Risk / Return Rank
XRAY
WST
XRAY vs. WST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DENTSPLY SIRONA Inc. (XRAY) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XRAY | WST | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.40 | 0.30 | -0.70 |
Sortino ratioReturn per unit of downside risk | -0.30 | 0.83 | -1.14 |
Omega ratioGain probability vs. loss probability | 0.96 | 1.10 | -0.14 |
Calmar ratioReturn relative to maximum drawdown | -0.48 | 0.53 | -1.01 |
Martin ratioReturn relative to average drawdown | -0.91 | 1.10 | -2.01 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XRAY | WST | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.40 | 0.30 | -0.70 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.74 | -0.06 | -0.68 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.41 | 0.41 | -0.82 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.37 | -0.14 |
Correlation
The correlation between XRAY and WST is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
XRAY vs. WST - Dividend Comparison
XRAY's dividend yield for the trailing twelve months is around 4.14%, more than WST's 0.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XRAY DENTSPLY SIRONA Inc. | 4.14% | 5.60% | 3.37% | 1.57% | 1.57% | 0.77% | 0.76% | 0.66% | 0.94% | 0.53% | 0.54% | 0.48% |
WST West Pharmaceutical Services, Inc. | 0.34% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% |
Drawdowns
XRAY vs. WST - Drawdown Comparison
The maximum XRAY drawdown since its inception was -84.28%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for XRAY and WST.
Loading graphics...
Drawdown Indicators
| XRAY | WST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.28% | -59.29% | -24.99% |
Max Drawdown (1Y)Largest decline over 1 year | -40.54% | -24.70% | -15.84% |
Max Drawdown (5Y)Largest decline over 5 years | -84.28% | -59.29% | -24.99% |
Max Drawdown (10Y)Largest decline over 10 years | -84.28% | -59.29% | -24.99% |
Current DrawdownCurrent decline from peak | -81.29% | -46.22% | -35.07% |
Average DrawdownAverage peak-to-trough decline | -20.14% | -16.79% | -3.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.16% | 12.05% | +9.11% |
Volatility
XRAY vs. WST - Volatility Comparison
DENTSPLY SIRONA Inc. (XRAY) has a higher volatility of 15.69% compared to West Pharmaceutical Services, Inc. (WST) at 9.11%. This indicates that XRAY's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XRAY | WST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.69% | 9.11% | +6.58% |
Volatility (6M)Calculated over the trailing 6-month period | 35.69% | 24.91% | +10.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.94% | 41.43% | +7.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.00% | 40.04% | -3.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.42% | 34.28% | +0.14% |
Financials
XRAY vs. WST - Financials Comparison
This section allows you to compare key financial metrics between DENTSPLY SIRONA Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XRAY vs. WST - Profitability Comparison
XRAY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, DENTSPLY SIRONA Inc. reported a gross profit of 443.00M and revenue of 961.00M. Therefore, the gross margin over that period was 46.1%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a gross profit of 303.90M and revenue of 805.00M. Therefore, the gross margin over that period was 37.8%.
XRAY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, DENTSPLY SIRONA Inc. reported an operating income of 268.00M and revenue of 961.00M, resulting in an operating margin of 27.9%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported an operating income of 157.10M and revenue of 805.00M, resulting in an operating margin of 19.5%.
XRAY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, DENTSPLY SIRONA Inc. reported a net income of -145.00M and revenue of 961.00M, resulting in a net margin of -15.1%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a net income of 132.10M and revenue of 805.00M, resulting in a net margin of 16.4%.